Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. [electronic resource]
Producer: 20070920Description: 1105-11 p. digitalISSN:- 0006-4971
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Asparaginase -- administration & dosage
- B-Lymphocytes -- drug effects
- Cell Lineage
- Central Nervous System Neoplasms -- prevention & control
- Child
- Child, Preschool
- Disease-Free Survival
- Female
- Humans
- Infant
- Infusions, Intravenous
- Injections, Intramuscular
- Injections, Spinal
- Male
- Mercaptopurine -- administration & dosage
- Methotrexate -- administration & dosage
- Pilot Projects
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prednisone -- administration & dosage
- Remission Induction
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.